Product Information
MI-538 is a novel cytostatic drug that exhibits selective toxicity to leukemia cells. The compound has been shown to inhibit proliferation of leukemia cells in vivo and in vitro. MI-538 is a molecule inhibitor that interacts with the cyanoindole target, which is involved in cellular differentiation, cell cycle progression, and chromosomal stability. In vivo studies have shown that MI-538 has a good pharmacokinetic profile and does not accumulate in the body. It has also been shown to have an optimized pharmacokinetic profile and does not cause any adverse effects on healthy cells.
Chemical properties
Technical inquiry about: 3D-HZC41710 MI-538
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
